RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.22B
AUM Growth
+$986M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
109
New
Increased
Reduced
Closed

Top Buys

1
+$236M
2
+$226M
3
+$206M
4
ICVX
Icosavax, Inc. Common Stock
ICVX
+$171M
5
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$171M

Top Sells

1
+$112M
2
+$95.8M
3
+$57.6M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$56.4M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$56.1M

Sector Composition

1 Healthcare 99.06%
2 Financials 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-2,003,653
102
– –
-977,503
103
– –
-255,277
104
– –
-15,000
105
– –
-584,000
106
– –
-156,250
107
– –
-2,200,000
108
– –
-5,290,481
109
– –
-233,333
1 2 3 4
5